Capilia Flu Neo can provide rapid and accurate detection of influenza A and/or B viral antigens from symptomatic patients. No special instruments or equipment are required.
Influenza spreads around the world in seasonal epidemics, resulting in about 3 to 5 million annual cases of severe illness and about 250,000 to 500,000 annual deaths, rising to millions in some pandemic years. Common symptoms are chills, fever, sore throat, muscle pains, headache, coughing, weakness/fatigue and general discomfort.
Diagnosis is difficult because the initial symptoms can be similar to those caused by other infectious agents. The influenza A virus is usually more prevalent and is associated with the most serious influenza epidemics, while influenza B infections usually present more mild symptoms. Because the influenza virus is highly contagious, rapid diagnosis and prompt treatment can have a positive effect on public health. And the ability to distinguish between A or B antigens can help the physician to prescribe an appropriate antiviral therapy. Administration of antiviral therapy within 48 hours of symptom onset is recommended for more rapid reduction of symptoms and to reduce viral shedding.
After completion, Goffin Molecular Technologies will contact you as soon as possible.